It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Originally posted by juggalo77
www.rinf.com... soooooooooooo curing people of cancer dosent fit in with their business plan,and these people are supposed to be in the business of helping people arnt they???? not good
Originally posted by Gunpowder Plot
Why save people even if we have the technology or the means? If we stall the disease, we can make money with treatments which will prolong your pain. We can offer medication which will get you by. If we fix the problem right off the bat, no one makes money.
Pretty good assessment?
Originally posted by Beefcake
Holy smokes i just watch the video last night and now its gone. Its not like the video was new it was an older story. Come on it was CTV news they aren't strict on terms of use you can find tons of their videos online.
Either way the video is still up under a different name.
Go ahead and post this in at the front of the thread.
A controlled clinical trial of DCA for the treatment of congenital lactic acidosis in children found that the drug was well tolerated at a dose of 12.5 mg/kg every 12 hours and blunted the increase in circulating lactate following a meal [5]. Patients received placebo for 6 months and then were randomly assigned to receive an additional 6 months of placebo or DCA. However, the drug failed to improve neurologic outcome. The efficacy of DCA was also evaluated for the treatment of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) [6]. The clinical trial ended early because of onset or worsening peripheral toxicity; all 15 of 15 patients randomized to DCA (25 mg/kg/day) were removed from the trial compared to 4 of 15 patients randomized to placebo. The authors concluded that DCA-associated neuropathy dominated the assessment of any potential benefit in MELAS.
Originally posted by Phage
reply to post by Guidance.Is.Internal
Maybe there's a good reason for it not to be sold over the counter.
A controlled clinical trial of DCA for the treatment of congenital lactic acidosis in children found that the drug was well tolerated at a dose of 12.5 mg/kg every 12 hours and blunted the increase in circulating lactate following a meal [5]. Patients received placebo for 6 months and then were randomly assigned to receive an additional 6 months of placebo or DCA. However, the drug failed to improve neurologic outcome. The efficacy of DCA was also evaluated for the treatment of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) [6]. The clinical trial ended early because of onset or worsening peripheral toxicity; all 15 of 15 patients randomized to DCA (25 mg/kg/day) were removed from the trial compared to 4 of 15 patients randomized to placebo. The authors concluded that DCA-associated neuropathy dominated the assessment of any potential benefit in MELAS.
www.highlighthealth.com...
Perhaps more testing is in order to find out how it can be used in such a way as to avoid the toxicity. People self administering it is certainly not going to find that out.
Originally posted by Guidance.Is.Internal
Caveat emptor - the way it should be in a free country ...
Originally posted by Chovy
They don't care about your health... They care about how much money you have. And how much they can take before you die, so a cure would be a bad thing for big pharma.
Every day Americans are subjected to a barrage of advertising by the pharmaceutical industry. Mixed in with the pitches for a particular drug—usually featuring beautiful people enjoying themselves in the great outdoors—is a more general message. Boiled down to its essentials, it is this: "Yes, prescription drugs are expensive, but that shows how valuable they are. Besides, our research and development costs are enormous, and we need to cover them somehow. As 'research-based' companies, we turn out a steady stream of innovative medicines that lengthen life, enhance its quality, and avert more expensive medical care. You are the beneficiaries of this ongoing achievement of the American free enterprise system, so be grateful, quit whining, and pay up." More prosaically, what the industry is saying is that you get what you pay for.
Is any of this true? Well, the first part certainly is. Prescription drug costs are indeed high—and rising fast. Americans now spend a staggering $200 billion a year on prescription drugs, and that figure is growing at a rate of about 12 percent a year (down from a high of 18 percent in 1999).[1] Drugs are the fastest-growing part of the health care bill—which itself is rising at an alarming rate. The increase in drug spending reflects, in almost equal parts, the facts that people are taking a lot more drugs than they used to, that those drugs are more likely to be expensive new ones instead of older, cheaper ones, and that the prices of the most heavily prescribed drugs are routinely jacked up, sometimes several times a year.
1. The purpose and driving force of the pharmaceutical industry is to increase sales of pharmaceutical drugs for ongoing diseases and to find new diseases to market existing drugs.
2. By this very nature, the pharmaceutical industry has no interest in curing diseases. The eradication of any disease inevitably destroys a multi-billion dollar market of prescription drugs. Therefore, pharmaceutical drugs are primarily developed to relieve symptoms, but not to cure.
3. If eradication therapies for diseases are discovered and developed, the industry has a basic interest to suppress, discredit and obstruct these medical breakthroughs in order to make sure that diseases continue as the very basis for a lucrative prescription drug market.
4. The economic interest of the pharmaceutical industry is the main reason why no medical breakthrough has been made for the control of the most common diseases such as cardiovascular disease, high blood pressure, heart failure, diabetes, cancer, and osteoporosis, and why these diseases continue like epidemics on a worldwide scale.
5. For the same economic reasons, the pharmaceutical industry has now formed an international cartel by the code name "Codex Alimentarius" with the aim to outlaw any health information in connection with vitamins and to limit free access to natural therapies on a worldwide scale.
6. At the same time, the pharmaceutical companies withhold public information about the effects and risks of prescription drugs and life-threatening side effects are omitted or openly denied.
7. In order to assure the status quo of this deceptive scheme, a legion of pharmaceutical lobbyists is employed to influence legislation, control regulatory agencies (e.g., FDA), and manipulate medical research and education. Expensive advertising campaigns and PR agencies are used to deceive the public.
8. Millions of people and patients around the world are defrauded twice: A major portion of their income is used to finance the exploding profits of the pharmaceutical industry. In return, they are offered a medicine that does not even cure.